Association between soluble PD-L1 and prognosis of non-small cell lung cancer (NSCLC) patients treated with immunotherapy

被引：0
|
作者：
Dellepiane, C. [1 ]
Coco, S. [1 ]
Dal Bello, M. G. [1 ]
Rossi, G. [1 ]
Rijavec, E. [2 ]
Biello, F. [3 ]
Tagliamento, M. [1 ]
Longo, L. [1 ]
Mora, M. [4 ]
Anselmi, G. [4 ]
Alama, A. [1 ]
Bennicelli, E. [1 ]
Grossi, F. [2 ]
Zullo, L. [1 ]
Beshiri, K. [1 ]
Bottini, A. [1 ]
Pronzato, P. [1 ]
Genova, C. [1 ]
机构：
[1] IRCCS Osped Policlin San Martino, Lung Canc Unit, Genoa, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Med Oncol Unit, Milan, Italy
[3] Azienda Osped Univ Maggiore Carita, Med Oncol Unit, Novara, Italy
[4] IRCCS Osped Policlin San Martino, Pathol Unit, Genoa, Italy
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1632
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1318P
引用
收藏
页码：S851 / S851
页数：1
相关论文
共 50 条
  • [1] Soluble PD-L1 shows no association to relapse and overall survival in stage non-small cell lung cancer (NSCLC)
    Mildner, F. O.
    Sykora, M. M.
    Hackl, H.
    Amann, A.
    Zelger, B.
    Sprung, S.
    Buch, M. L.
    Nocera, F.
    Moser, P.
    Maier, H.
    Augustin, F.
    Manzl, C.
    Kocher, F.
    Pircher, A.
    Lindenmann, J.
    Mykoliuk, I
    Raftopoulou, S.
    Kargl, J.
    Wolf, D.
    Sopper, S.
    Gamerith, G.
    LUNG CANCER, 2024, 196
  • [2] Association of PD-L1 expression with hotspot mutations in non-small cell lung cancer (NSCLC).
    Wan, Renping
    Zhang, Xiaoni
    Qu, Hongyue
    Li, Hui
    Li, Yingmei
    Xu, Mingyan
    Xiao, Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Liquid Biopsy Based Monitoring of PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients for Immunotherapy
    Singh, G.
    Leong, M.
    Sylvester, S.
    Lee, Y.
    Johnson, C.
    Wu, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1006 - 1006
  • [4] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430
  • [5] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [6] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] PD-L1 expression and survival in patients with non-small cell lung cancer (NSCLC) in Korea
    Sun, Jong-Mu
    Zhou, Wei
    Choi, Yoon-La
    Choi, So-Jung
    Kim, Se Eun
    Wang, Zhen
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Weiner, Russell
    Park, Minjin
    Kim, Hong Kwan
    Choi, Yong Soo
    Shim, Young Mog
    Kim, Jhingook
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
  • [9] PD-L1 heterogeneity in patients with non-small cell lung cancer
    Wei, Zhigang
    Fan, Linlin
    Yang, Xia
    Li, Jie
    Zhan, Xuemei
    Ye, Xin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (05) : E268 - E274
  • [10] PD-L1 immunohistochemistry in patients with non-small cell lung cancer
    Jotatsu, Takanobu
    Oda, Keishi
    Yatera, Kazuhiro
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S2127 - S2129
12345